Fingerprint
Dive into the research topics of 'A phase II study of bortezomib in the treatment of metastatic malignant melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of bortezomib in the treatment of metastatic malignant melanoma
Svetomir N. Markovic, Susan M. Geyer, Fitzroy Dawkins, William Sharfman, Mark Albertini, William Maples, Paula M. Fracasso, Tom Fitch, Patricia LoRusso, Alex A. Adjei, Charles Erlichman
Research output: Contribution to journal › Article › peer-review
124
Scopus
citations